This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Coagulation Defects
and you are
between 18 and 55
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study is a Phase 1, single-center, open-label, ascending dose study which will assess the safety and tolerability of 5 doses of spray-dried solvent/detergent treated plasma (Resusix®) in healthy volunteers.

Provided treatments

  • Biological: Spray-dried S/D-treated Plasma
  • Drug: Spray-dried S/D-treated plasma
  • Biological: Spray-dried S/D-treated Plasma
  • Biological: Spray-dried S/D-treated Plasma
  • Biological: Spray-dried S/D-treated Plasma

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01589666. The sponsor of the trial is Entegrion, Inc. and it is looking for 27 volunteers for the current phase.
Official trial title:
Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers